Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page updates include revision v3.4.2 with dates 2026-02-10 and 2026-02-07, and the earlier funding lapse notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:23:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now includes a government funding lapse notice banner and an updated revision note (v3.4.1) with new dates 2026-02-03 and 2026-01-31; earlier dates 2026-01-27 and 2026-01-24 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:10:31.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    UI/metadata updates were made: the glossary toggle appears, revision notes show v3.4.0 with dates 2026-01-27 and 2026-01-24, and FEAR Act wording was updated. These changes do not alter the study content or results.
    Difference
    0.3%
    Check dated 2026-01-27T23:46:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Two new update entries were added to the Study Record Dates (last update posted 2026-01-20 and last update submitted 2026-01-16), while the previous entries (2026-01-13 and 2026-01-10) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T21:40:56.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated to v3.3.4 with added timestamps 2026-01-13 and 2026-01-10 and removed 2026-01-03 and 2026-01-06. No trial content, eligibility criteria, outcomes, or other study data were changed.
    Difference
    0.1%
    Check dated 2026-01-13T17:39:38.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    New update date entries were added (2026-01-03 and 2026-01-06) and older ones removed (2025-12-26 and 2025-12-29). The core study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-01-06T16:38:38.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.